Increased core fucosylation has been detected in the serum of patients with prostate cancer, is associated with disease progression [43,67,68] (Table 1), and may influence prostate cancer cell trafficking through an E-selectin dependent mechanism [56]. The gene discussed is SELE; the disease is Familial prostate cancer.